WallStreetZenWallStreetZen

NASDAQ: OMGA
Omega Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for OMGA

Based on 2 analysts offering 12 month price targets for Omega Therapeutics Inc.
Min Forecast
$11.00+250.32%
Avg Forecast
$11.50+266.24%
Max Forecast
$12.00+282.17%

Should I buy or sell OMGA stock?

Based on 2 analysts offering ratings for Omega Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OMGA stock forecasts and price targets.

OMGA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$11.00+250.32%2023-09-01
Chardan Capital
Top 9%
92
Strong BuyReiterates$12.00+282.17%2023-08-04

1 of 1

Forecast return on equity

Is OMGA forecast to generate an efficient return?
Company
N/A
Industry
0.91%
Market
28.82%

Forecast return on assets

Is OMGA forecast to generate an efficient return on assets?
Company
N/A
Industry
0.07%

OMGA revenue growth forecast

How is OMGA forecast to perform vs Biotechnology companies and vs the US market?
Company
469.91%
Industry
35.95%
Market
8.15%
OMGA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OMGA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OMGA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OMGA$3.14$11.50+266.24%Strong Buy
MREO$1.35$4.50+233.33%Strong Buy
IMMP$1.98$8.50+329.29%Strong Buy
VAXX$1.38$7.00+407.25%Buy
XFOR$1.04$3.67+252.60%Strong Buy
View Top Biotech Stocks

Omega Therapeutics Stock Forecast FAQ

Is Omega Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: OMGA) stock is to Strong Buy OMGA stock.

Out of 2 analysts, 1 (50%) are recommending OMGA as a Strong Buy, 1 (50%) are recommending OMGA as a Buy, 0 (0%) are recommending OMGA as a Hold, 0 (0%) are recommending OMGA as a Sell, and 0 (0%) are recommending OMGA as a Strong Sell.

If you're new to stock investing, here's how to buy Omega Therapeutics stock.

What is OMGA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: OMGA) forecast ROE is N/A, which is considered weak.

What is OMGA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year OMGA price target, the average OMGA price target is $11.50, with the highest OMGA stock price forecast at $12.00 and the lowest OMGA stock price forecast at $11.00.

On average, Wall Street analysts predict that Omega Therapeutics's share price could reach $11.50 by Sep 1, 2024. The average Omega Therapeutics stock price prediction forecasts a potential upside of 266.24% from the current OMGA share price of $3.14.

What is OMGA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: OMGA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.